Alison Kennedy

916 citations
8 papers · 117 indexed · h-index 4
Topics
Acute Myeloid Leukemia Research (3 papers)Immunodeficiency and Autoimmune Disorders (2 papers)Cancer Genomics and Diagnostics (2 papers)

In The Last Decade

Alison Kennedy

8 papers receiving 116 citations

Peers

Alison Kennedy
Comparison fields: 5 of 49
  • Hematology 59
  • Molecular Biology 39
  • Cancer Research 16
  • Public Health, Environmental and Occupational Health 15
  • Immunology 15
Replace Jiří Hák with:
Jiří Hák Czechia
Olena O Shevchuk Canada
Nathalie Jacque France
J.-Th. Fischer Germany
Elen Oliveira Brazil
Kristin L Koenig United States
Giovangiacinto Paterno Italy
Anne Roggy France
Connor Sweeney United Kingdom
A. Almqvist Finland
Alison Kennedy relative to Jiří Hák Czechia Jiří Hák's profile →
Citations per field
00.5×
Jiří Hák · 1×
Citations per year

Countries citing papers authored by Alison Kennedy

Since Specialization
Citations

This map shows the geographic impact of Alison Kennedy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Kennedy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Kennedy more than expected).

Fields of papers citing papers by Alison Kennedy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Kennedy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Kennedy. The network helps show where Alison Kennedy may publish in the future.

Co-authorship network of co-authors of Alison Kennedy

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Kennedy. A scholar is included among the top collaborators of Alison Kennedy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Kennedy. Alison Kennedy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 3
2 6
3 48
4 49
5
Comparison between Centcor CA 125 and CA 125 II assays.
1
6 3
7 1
8 6

About Alison Kennedy

Alison Kennedy is a scholar working on Hematology, Genetics and Clinical Biochemistry, having authored 8 papers that have together received 117 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Hematology (59 citations), Industrial and Manufacturing Engineering (9 citations) and Cancer Research (16 citations). Alison Kennedy has collaborated with scholars based in Australia, United Kingdom and Ireland. Frequent co-authors include Sally Jeffries, Fernando J. Calero‐Nieto, Robert Danby, Pedro M. Quirós, Marlen Metzner, Larissa S. Carnevalli, Paul Ferguson, Claudia Walter, George S. Vassiliou and Andrew Peniket. Their work appears in journals such as Nature Communications, Blood and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026